Adult versus Embryonic Stem Cell debate may become “obsolete” | The deVeber Institute for Bioethics and Social Research: The classic stem cell debate centres on adult versus embryonic sources. In theory, though ethically controversial, embryonic stem cells are more promising for their pluripotency or ability to develop into many different cell types. Adult stem cells are multipotent and more limited in their potential to differentiate. However, new technologies are developing that can resolve this conundrum.
. . . Still, adult stem cell therapies themselves are not without dilemma. “One of the drugs in my chemotherapy drug trial cost about $40 000 for the twelve week course. Another drug that I took on a monthly basis was about $4000 a month,” explained McCallum. “The stem cell transplant as it’s valued by insurance companies in the United States is about a quarter of a million dollars”
'via Blog this'